HOIL and water: the two faces of HOIL-1 deficiency.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Lessons learned from the study of human inborn errors of innate immunity.The Journal of allergy and clinical immunology · 2019
   Review
2. Toward an Inclusive, Congruent, and Precise Definition of Autoinflammatory Diseases.Frontiers in immunology · 2017
   Article
3. Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease.Proceedings of the National Academy of Sciences of the United States of America · 2016
   Article
4. Advances in the genetically complex autoinflammatory diseases.Seminars in immunopathology · 2015
   Review
5. New players driving inflammation in monogenic autoinflammatory diseases.Nature reviews. Rheumatology · 2015
   Review
6. When less is more: primary immunodeficiency with an autoinflammatory kick.Current opinion in allergy and clinical immunology · 2014
   Review

Corrections and comments

• Comment on
  Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency.2012

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as